The use of ampligen alone and in combination with ganciclovir and coumermycin A1 for the treatment of ducks congenitally-infected with duck hepatitis B virus.
about
C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infectionA new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivoIn vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virusLong-term therapy with the guanine nucleoside analog penciclovir controls chronic duck hepatitis B virus infection in vivo.Cell-based and animal models for hepatitis B and C viruses.Inhibition of duck hepatitis B virus replication by 9-(2-phosphonylmethoxyethyl)adenine, an acyclic phosphonate nucleoside analoguePoly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.The guanine nucleoside analog penciclovir is active against chronic duck hepatitis B virus infection in vivo.Interaction between ganciclovir and foscarnet as inhibitors of duck hepatitis B virus replication in vitro.Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.2',3'-dideoxy-3'-fluoroguanosine inhibits duck hepatitis B virus in vivo.Long-term productive episomal hepatitis B virus replication in primary cultures of adult human hepatocytes infected in vitro.Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B.
P2860
Q27486152-86D821F1-130C-43E0-9DE3-8DB3EBB2BB50Q27490484-DE666F73-1B78-4C2E-9521-7473B36A6B65Q28369279-48746E21-B215-4278-8AF4-61F5C8B0C9A1Q33698569-EE3ED291-7A8B-4EAE-8BF4-35CD76747E3DQ33702348-D03737E7-E2DE-4733-957E-8B61C330D4BBQ33702993-B8AF20CF-A2CD-4125-A88E-51334A8BD0AEQ34262302-20D0BB26-57E8-42EA-99D5-57A28226F8A6Q35122451-C8ECAC5A-79AE-4143-98E4-2AD95973D016Q35124345-38998BD3-6431-46EE-9155-92B8CF9D828EQ38270733-2DFF65D6-67A3-4AA8-BB5A-4E7638A5FC96Q38465842-6B3C3FD0-71C0-48B9-8C59-7F6A5C4DB439Q45766479-7FDC75E5-ADF3-4D6F-A991-F09499EE1337Q47553095-C854708A-388D-440B-AF24-128601E7021F
P2860
The use of ampligen alone and in combination with ganciclovir and coumermycin A1 for the treatment of ducks congenitally-infected with duck hepatitis B virus.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
The use of ampligen alone and ...... d with duck hepatitis B virus.
@en
The use of ampligen alone and ...... d with duck hepatitis B virus.
@nl
type
label
The use of ampligen alone and ...... d with duck hepatitis B virus.
@en
The use of ampligen alone and ...... d with duck hepatitis B virus.
@nl
prefLabel
The use of ampligen alone and ...... d with duck hepatitis B virus.
@en
The use of ampligen alone and ...... d with duck hepatitis B virus.
@nl
P2093
P1433
P1476
The use of ampligen alone and ...... d with duck hepatitis B virus.
@en
P2093
Locarnini S
P304
P356
10.1016/0166-3542(93)90051-J
P577
1993-06-01T00:00:00Z